Related references
Note: Only part of the references are listed.Empirical antifungal therapy in selected patients with persistent febrile neutropenia
M. Aguilar-Guisado et al.
BONE MARROW TRANSPLANTATION (2010)
Clinically Driven Diagnostic Antifungal Approach in Neutropenic Patients: A Prospective Feasibility Study
Corrado Girmenia et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin Bin patients after allo-SCT
H. Hebart et al.
BONE MARROW TRANSPLANTATION (2009)
An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality
F. L. Dignan et al.
BONE MARROW TRANSPLANTATION (2009)
A Multicenter, Double-Blind Trial of a High-Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive Candidiasis
Robert F. Betts et al.
CLINICAL INFECTIOUS DISEASES (2009)
Empirical versus Preemptive Antifungal Therapy for High-Risk, Febrile, Neutropenic Patients: A Randomized, Controlled Trial
Catherine Cordonnier et al.
CLINICAL INFECTIOUS DISEASES (2009)
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2009)
Efficacy and safety of intravenous itraconazole as empirical antifungal therapy for persistent fever in neutropenic patients with hematological malignancies in Japan
Kensuke Ohta et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2009)
An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients
C. Viscoli et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients
R. A. Barnes et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
Efficacy and safety of micafungin, an echinocandin antifungal agent, on invasive fungal infections in patients with hematological disorders
Kazuo Tamura et al.
LEUKEMIA & LYMPHOMA (2009)
Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy
Ray Y. Hachem et al.
CANCER (2008)
Treatment of aspergillosis: Clinical practice guidelines of the infectious diseases society of America
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2008)
Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia:: A randomized, placebo-controlled trial
Bart J. Rijnders et al.
CLINICAL INFECTIOUS DISEASES (2008)
Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: Systematic review and meta-analysis
Eyal Robenshtok et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2007)
Anidulafungin versus fluconazole for invasive candidiasis
Annette C. Reboli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial
Ernst-Ruediger Kuse et al.
LANCET (2007)
Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients
Simone Cesaro et al.
BMC INFECTIOUS DISEASES (2007)
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease
Andrew J. Ullmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation:: a retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
Rodrigo Martino et al.
BLOOD (2006)
Galactomannan and computed tomography - Based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: A prospective feasibility study
J Maertens et al.
CLINICAL INFECTIOUS DISEASES (2005)
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial
BJ Kullberg et al.
LANCET (2005)
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia
TJ Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center
T Fukuda et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2004)
Comparison of caspofungin and amphotericin B for invasive candidiasis.
J Mora-Duarte et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
R Herbrecht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
